Zealand Pharma A/S (ZEAL) — Cash Flow Quality Index
Zealand Pharma A/S (ZEAL) has a Cash Flow Quality Index of 1.12x as of June 2025. Operating cash flow of Dkr8.52 Billion exceeds net income of Dkr7.57 Billion, indicating high earnings quality where cash backs reported profits. Explore Zealand Pharma A/S cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Zealand Pharma A/S Cash Flow Quality Index (2011–2025)
Historical Cash Flow Quality Index for Zealand Pharma A/S across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check cash flow reinvestment rate of Zealand Pharma A/S to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Zealand Pharma A/S (2011–2025)
Year-by-year earnings quality comparison for Zealand Pharma A/S. For live market cap and the full company financial profile, see Zealand Pharma A/S (ZEAL) market capitalisation.
| Year | Quality Index | Operating CF (DKK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.01x | Dkr6.53 Billion | Dkr6.46 Billion | ▲ +227.8% |
| 2018 | -0.79x | Dkr-460.40 Million | Dkr581.28 Million | ▼ -142.0% |
| 2012 | 1.88x | Dkr68.54 Million | Dkr36.37 Million | ▲ +1495.7% |
| 2011 | -0.14x | Dkr-1.81 Million | Dkr13.38 Million | — |